A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent

checkorphan
Learn more about:
Acute mountain sickness
Related Clinical Trial
Colorado-Oregon Altitude Study The Effects of Intermittent Hypoxia on Acute Hypoxic Injury Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude The Pre-acclimatization Augmented Extreme Altitude Expedition Effect of Altitude on Iron Absorption in Iron Depleted Women Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD HIGH Altitude CArdiovascular REsearch Latin America Population Study Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude. Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance Iron Status and Cardiopulmonary Physiology Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude. Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude The Psychophysiological Effect of Simulated and Terrestrial Altitude Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude AZ, MZ, and the Pulmonary System Response to Hypoxia Study of the Effects of Iron Levels on the Lungs at High Altitude Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort Three New Ideas to Protect Special Forces From the Stress of High Altitude Breathing Training to Improve Human Performance at High Altitude Oxidative Stress in Hypobaric Hypoxia Safety Evaluation of Aminophylline and Methazolamide Decompression Tables for Diving at Altitude Chronic Mountain Sickness, Systemic Vascular Function Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness Inhaled Budesonide for Altitude Illness Prevention Sickness Evaluation at Altitude With Acetazolamide at Relative Doses Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) Drug Combination on Exercise Performance at High Altitude Acclimatization Mechanisms During Ascent to 7500m Prevention of Acute Mountain Sickness by Intermittent Hypoxia Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent Training in Hypoxia to Prevent Acute Mountain Sickness Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness Inhaled Budesonide and Acute Mountain Sickness Altitude Sickness Prevention and Efficacy of Comparative Treatments Alternative Treatments in Acute Mountain Sickness Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Brief Title

A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent

Official Title

Double Blind, Placebo Controlled Randomised Trial of Acetazolamide Versus Placebo in the Prevention of Acute Mountain Sickness During Rapid Ascent

Brief Summary

      Acute mountain sickness is a common ailment in people venturing over 2500 m altitude.
      Pilgrims to high altitudes are at an added risk since they are unaware and they gain height
      faster than the recommendations. Acetazolamide is the standard treatment and prophylaxis of
      acute mountain sickness. There are no randomized controlled trials that have studied
      protective effects of Acetazolamide in rapid ascent, and there are few conflicting studies
      regarding this matter.

      This study is a randomized, double blinded, placebo controlled trial of Acetazolamide versus
      placebo in 380 healthy individuals travelling to Gosaikunda Lake of Nepal in rates of ascent
      that are faster than the recommendations. Acetazolamide 125 mg twice daily and a placebo will
      be randomly assigned for 3 days and participants will be assessed at 3 stations.

      This study will undertake to establish the role of Acetazolamide in Rapid Ascent and will be
      the first RCT done in this issue.

      The investigators hypothesize that Acetazolamide 125mg twice daily given before rapid ascent
      to high altitude in Nepalese pilgrims will not be superior to placebo in decreasing both the
      incidence and severity of acute mountain sickness.

Study Phase

Phase 4

Study Type

Interventional

Primary Outcome

Diagnosis of acute mountain sickness

Secondary Outcome

 Blood oxygen saturation

Condition

Acute Mountain Sickness

Intervention

Acetazolamide

Study Arms / Comparison Groups

 Acetazolamide
Description:

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Drug

Estimated Enrollment

380

Start Date

August 2011

Completion Date

October 2011

Primary Completion Date

October 2011

Eligibility Criteria

        Inclusion Criteria:

          -  Nepalese national

          -  Aged 18 to 65

          -  Travelling directly from Dhunche to Gosainkunda

          -  Rapid ascent as defined by ascent within 3 days

        Exclusion Criteria:

          -  Use of any drugs for the prevention of altitude sickness or headache

          -  Current illness

          -  Current altitude sickness (more than one mild symptom on the Lake Louise Questionnaire
             (LLQ), or oxygen saturation less than 75%

          -  Known to be pregnant or cannot exclude the possibility of being pregnant, or have
             missed menses by over 7 days

          -  One night within the last 30 days spent at an altitude of 4500 metres or above

          -  Residents of altitude more than 2500m

          -  A known drug allergy to sulfonamides.

          -  Treatment with any of the following in the last 2 days: acetazolamide (Diamox®),
             steroids (dexamethasone/decadron, prednisone), theophylline or diuretics (Lasix®),
             ibuprofen/motrin, naprosyn/naproxen, aspirin or acetaminophen.

          -  Any serious intracranial abnormalities such as history of brain tumours or
             pseudotumour cerebri

          -  Known severe uncontrolled headache syndrome

          -  Diagnosed renal function impairment, diabetes, cirrhosis of liver or liver dysfunction

Gender

All

Ages

18 Years - 65 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Buddha Basnyat, MD PhD, ,

Location Countries

Nepal

Location Countries

Nepal

Administrative Informations

NCT ID

NCT01418157

Organization ID

04NP

Responsible Party

Sponsor

Study Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

 University of Oxford

Study Sponsor

Buddha Basnyat, MD PhD, Principal Investigator, University of Oxford

Verification Date

June 2013